PDB22 LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART VERSUS SOLUBLE HUMAN INSULIN IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM
May 1, 2005, 00:00
10.1016/S1098-3015(10)62955-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)62955-5/fulltext
Title :
PDB22 LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART VERSUS SOLUBLE HUMAN INSULIN IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62955-5&doi=10.1016/S1098-3015(10)62955-5
First page :
Section Title :
Open access? :
No
Section Order :
392